中国医师杂志
中國醫師雜誌
중국의사잡지
JOURNAL OF CHINESE PHYSICIAN
2014年
5期
601-604
,共4页
周菊梅%朱苏雨%黄再捷%鲁琼辉%刘科%袁媛%汪洁%聂少麟
週菊梅%硃囌雨%黃再捷%魯瓊輝%劉科%袁媛%汪潔%聶少麟
주국매%주소우%황재첩%로경휘%류과%원원%왕길%섭소린
直肠肿瘤/外科学%直肠肿瘤/药物疗法%直肠肿瘤/放射疗法%治疗结果
直腸腫瘤/外科學%直腸腫瘤/藥物療法%直腸腫瘤/放射療法%治療結果
직장종류/외과학%직장종류/약물요법%직장종류/방사요법%치료결과
Rectal neoplasms/surgery%Rectal neoplasms/drug therapy%Rectal neoplasms/radiotherapy%Treatment outcome
目的 比较改良的术前短程同步放化疗与经典的术前长程同步放化疗对局部晚期中低位直肠癌的临床近期疗效和急性放射性毒性反应.方法 中低位局部晚期直肠癌按治疗方法分组,42例行改良的术前短程同步放化疗(短程组),45例行经典的术前长程同步放化疗(长程组).短程组剂量为30 ~ 39Gy/10~13 f/2~3周,配合5-Fu 225 mg/(m2·d)持续静脉泵入,休息3~4周行手术治疗.长程组靶区剂量45 ~50.4 Gy/25~28 f/5~6周,放疗的d1-4和d22-25配合5-Fu 400 mg/(m2·d)微电脑持续泵入,放疗完成后休息4~6周行手术.比较两组的临床近期疗效和急性放射性毒性反应.结果 短程组和长程组的总有效率(CR+ PR)分别为88.09%和86.67%,肿瘤消退分级(TRG)4级分别为14.29%和17.78%,保肛率分别为69.05%和71.11%,T分期降期率分别为76.19%和73.33%,N分期降期率分别为52.38%和57.78%,差异均无统计学意义(P>0.05).两组术后肠梗阻、吻合口瘘和伤口愈合不良的发生率差异无统计学意义(P>0.05).短程组的急性放射性下消化道反应明显低于长程组(P<0.05),而皮肤反应、膀胱反应、骨髓抑制差异无统计学意义(P>0.05).结论 短程组和长程组的临床有效率、病理反应率和保肛率相似,没有增加术后的并发症;短程组的下消化道放疗反应低于长程组,值得临床推广.
目的 比較改良的術前短程同步放化療與經典的術前長程同步放化療對跼部晚期中低位直腸癌的臨床近期療效和急性放射性毒性反應.方法 中低位跼部晚期直腸癌按治療方法分組,42例行改良的術前短程同步放化療(短程組),45例行經典的術前長程同步放化療(長程組).短程組劑量為30 ~ 39Gy/10~13 f/2~3週,配閤5-Fu 225 mg/(m2·d)持續靜脈泵入,休息3~4週行手術治療.長程組靶區劑量45 ~50.4 Gy/25~28 f/5~6週,放療的d1-4和d22-25配閤5-Fu 400 mg/(m2·d)微電腦持續泵入,放療完成後休息4~6週行手術.比較兩組的臨床近期療效和急性放射性毒性反應.結果 短程組和長程組的總有效率(CR+ PR)分彆為88.09%和86.67%,腫瘤消退分級(TRG)4級分彆為14.29%和17.78%,保肛率分彆為69.05%和71.11%,T分期降期率分彆為76.19%和73.33%,N分期降期率分彆為52.38%和57.78%,差異均無統計學意義(P>0.05).兩組術後腸梗阻、吻閤口瘺和傷口愈閤不良的髮生率差異無統計學意義(P>0.05).短程組的急性放射性下消化道反應明顯低于長程組(P<0.05),而皮膚反應、膀胱反應、骨髓抑製差異無統計學意義(P>0.05).結論 短程組和長程組的臨床有效率、病理反應率和保肛率相似,沒有增加術後的併髮癥;短程組的下消化道放療反應低于長程組,值得臨床推廣.
목적 비교개량적술전단정동보방화료여경전적술전장정동보방화료대국부만기중저위직장암적림상근기료효화급성방사성독성반응.방법 중저위국부만기직장암안치료방법분조,42례행개량적술전단정동보방화료(단정조),45례행경전적술전장정동보방화료(장정조).단정조제량위30 ~ 39Gy/10~13 f/2~3주,배합5-Fu 225 mg/(m2·d)지속정맥빙입,휴식3~4주행수술치료.장정조파구제량45 ~50.4 Gy/25~28 f/5~6주,방료적d1-4화d22-25배합5-Fu 400 mg/(m2·d)미전뇌지속빙입,방료완성후휴식4~6주행수술.비교량조적림상근기료효화급성방사성독성반응.결과 단정조화장정조적총유효솔(CR+ PR)분별위88.09%화86.67%,종류소퇴분급(TRG)4급분별위14.29%화17.78%,보항솔분별위69.05%화71.11%,T분기강기솔분별위76.19%화73.33%,N분기강기솔분별위52.38%화57.78%,차이균무통계학의의(P>0.05).량조술후장경조、문합구루화상구유합불량적발생솔차이무통계학의의(P>0.05).단정조적급성방사성하소화도반응명현저우장정조(P<0.05),이피부반응、방광반응、골수억제차이무통계학의의(P>0.05).결론 단정조화장정조적림상유효솔、병리반응솔화보항솔상사,몰유증가술후적병발증;단정조적하소화도방료반응저우장정조,치득림상추엄.
Objective To compare clinical recent efficacy and acute radiation toxicity reaction of the improved short-term and classic long-term preoperative chemoradiation in the treatment of locally advanced middle-low rectal cancers.Methods Patients with middle-low locally advanced rectal cancers were randomly classified into two groups,including the improved preoperative short-term chemoradiation (short-term group; n =42),and the classic preoperative long-term chemoradiation (long-term group; n =45).The dose in the short-term group was 30 ~ 39 Gy/10 ~ 13 f/2 ~ 3 weeks,with 5-Fu 225 mg/(m2 · d) continuous intravenous pumping; after completion of radiotherapy,the patients rest 3 ~ 4 weeks and went operation.The dose in the Long-term group was 45 ~ 50.4 Gy/25 ~28 f/5 ~6 weeks,radiation of d1-4 and d22-25 with 5-Fu 400 mg/(m2 · d) continuous intravenous pumping; after completion of radiotherapy,the patients rest 4 to 6 weeks and went operation.The clinical effect and recent acute radiation toxicity reactions were compared between two groups.Results For the short-term and long-term groups,the total effective rate (CR + PR) was 88.09% and 86.67%,respectively; TRG4 level was 14.29% and 17.78%,respectively; sphincter-saving rate was 69.05% and 71.11%,respectively; the T stage reduction rate was 76.19% and 73.33%,respectively; and N stage reduction rate was 52.38% and 57.78%,respectively; they were all no significant difference between two groups (P > 0.05).The postoperative incidence rate of intestinal obstruction and anastomotic fistula and poor wound healing were no significant difference between two groups (P > 0.05).The lower digestive tract response of acute radioactive in short-term group was significantly lower than long-term group (P < 0.05) ;while the skin reactions,bone marrow suppression and bladder reaction were no significant difference between two groups (P > 0.05).Conclusions Clinical effectiveness,pathological response rate,and sphincter-saving rate were similar between short-term and long-term groups.Postoperative complications were not increased in the short-term group relative to the long-term group.The lower digestive reaction is lower in the short-range group than in the long-term group.Thus,the optimized short-term preoperative chemoradiation is worth clinically popularizing in the treatment of locally advanced middle-low rectal cancers.